Recent Updates — PMCB

The Audit Committee of PharmaCyte Biotech, Inc. dismissed CBIZ CPAs P.C. as its independent registered public accounting firm and engaged Grassi & Co., CPAs, P.C. as the new auditor, effective October 14, 2026. The reports from CBIZ did not contain adverse opinions or qualifications, but disclosed material weaknesses in internal control over financial reporting for fiscal years ended April 30, 2026 and 2025, relating to insufficient segregation of duties and management review controls. Grassi was consulted on no accounting matters prior to engagement. PharmaCyte Biotech operates in the biotechnology industry.